Josephson L - Search Results

1

A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent.

Josephson L, Groman EV, Menz E, Lewis JM, Bengele H. Josephson L, et al. Magn Reson Imaging. 1990;8(5):637-46. doi: 10.1016/0730-725x(90)90143-p. Magn Reson Imaging. 1990. PMID: 1707120

2

The effects of iron oxides on proton relaxivity.

Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. Josephson L, et al. Magn Reson Imaging. 1988 Nov-Dec;6(6):647-53. doi: 10.1016/0730-725x(88)90088-4. Magn Reson Imaging. 1988. PMID: 2850434

3

Visualization of superior mesenteric lymph nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227.

Rogers JM, Lewis J, Josephson L. Rogers JM, et al. Among authors: josephson l. Magn Reson Imaging. 1994;12(8):1161-5. doi: 10.1016/0730-725x(94)90081-2. Magn Reson Imaging. 1994. PMID: 7854022

4

Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration.

Bengele HH, Palmacci S, Rogers J, Jung CW, Crenshaw J, Josephson L. Bengele HH, et al. Among authors: josephson l. Magn Reson Imaging. 1994;12(3):433-42. doi: 10.1016/0730-725x(94)92537-2. Magn Reson Imaging. 1994. PMID: 8007773

5

Use of AMI-227 as an oral MR contrast agent.

Rogers J, Lewis J, Josephson L. Rogers J, et al. Among authors: josephson l. Magn Reson Imaging. 1994;12(4):631-9. doi: 10.1016/0730-725x(94)92458-9. Magn Reson Imaging. 1994. PMID: 8057768

6

Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.

Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Weissleder R, et al. Among authors: josephson l. Radiology. 1990 May;175(2):489-93. doi: 10.1148/radiology.175.2.2326474. Radiology. 1990. PMID: 2326474

7

Arabinogalactan for hepatic drug delivery.

Groman EV, Enriquez PM, Jung C, Josephson L. Groman EV, et al. Among authors: josephson l. Bioconjug Chem. 1994 Nov-Dec;5(6):547-56. doi: 10.1021/bc00030a010. Bioconjug Chem. 1994. PMID: 7533005

8

The use of AMI-227 as an oral contrast agent for magnetic resonance imaging.

Rogers J, Lewis J, Josephson L. Rogers J, et al. Among authors: josephson l. Invest Radiol. 1994 Jun;29 Suppl 2:S81-2. doi: 10.1097/00004424-199406001-00027. Invest Radiol. 1994. PMID: 7928278 No abstract available.

9

Contrast agents for magnetic resonance imaging of the liver.

Josephson L, Groman E, Weissleder R. Josephson L, et al. Targeted Diagn Ther. 1991;4:163-87. Targeted Diagn Ther. 1991. PMID: 1797156 Review. No abstract available.

10

Antiviral activity of a conjugate of adenine-9-beta-D-arabinofuranoside 5'-monophosphate and a 9 kDa fragment of arabinogalactan.

Josephson L, Rutkowski JV, Paul K, Frigo T, Korba BE, Tennant B, Groman EV. Josephson L, et al. Antivir Ther. 1996 Aug;1(3):147-56. Antivir Ther. 1996. PMID: 11322248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters